As with any type of cancer, it could come back. Doctors call that “recurrent” soft tissue sarcoma. Your treatment for a recurrence would depend on whether it comes back in the same place or if it shows up in other parts of your body. Just like with the first time, the options might...
[21] Portera CA Jr, Ho V , Patel SR, et al. Alveolar soft part sarcoma: clinical course and patterns of metastasis in 70 patients treated at a single institution. Cancer 2001;91:585-91. [22] Chou YS, Liu CY, Chen WM, et al. Brain, the last fortress of sarcoma: similar dismal o...
343、腺泡状软组织肉瘤(alveolar soft part sarcoma,ASPS):病例&解析 342、成人胰母细胞瘤:病例&解析 341、卵巢颗粒细胞瘤(ovarian granulosa celltumor,OGCT):病例&解析 340、嗅神经母细胞瘤(ONB):病例&解析 339、可逆性胼胝体压...
Skip to Main content Journals & Books Help Search My accountSign inSoft Tissue Cancer In subject area: Pharmacology, Toxicology and Pharmaceutical Science Featured on this page
Soft tissue sarcoma after treatment for breast cancer—a Swedish population-based study. Eur J Cancer. 1998; 34 :2068–2075.Karlsson, P.; Holmberg, E.; Samuelsson, A.; Johansson, K.-A.; Wallgren, A. Soft tissue sarcoma after treatment for breast cancer--A Swedish population-based study....
In a register study all women in the West of Sweden Health Care Region with a breast cancer diagnosed between 1960 and 1980 (n = 13,490) were followed up in the Swedish Cancer Register to the end of 1988 for later occurrence of a soft tissue sarcoma (STS). Nineteen sarcomas were ...
Sarcoma, tumour of connective tissue (tissue that is formed from mesodermal, or mesenchymal, cells). Sarcomas are distinguished from carcinomas, which are tumours of epithelial tissues. Sarcoma is relatively rare in adults but is one of the more common m
Regional lymph node assessment, by ultrasound or cross-sectional imaging for synovial sarcoma, clear cell sarcoma, angiosarcoma, or epithelioid sarcoma, due to a higher risk of nodal involvement. Atypical lipomatous tumours (ALT) of the extremities without evidence of de-differentiation have an extrem...
Park and Graff Explore the Evolving Role of CDK4/6 Inhibitors in Metastatic Breast Cancer September 25th 2024 Adjuvant Ribociclib Approval Expands Access to CDK4/6 Inhibition in High-Risk HR+/HER2– Breast Cancer September 25th 2024 Experts Share Intriguing Early-Phase Sarcoma Studies From the 20...
Jonathan C. Trent, MD, PhD:I think it’s critical. This is a multidisciplinary disease, so every new patient at Sylvester Comprehensive Cancer Center is discussed at our multidisciplinary tumor board where we have not only a medical oncologist like us, but we also have our pathologists, radiol...